why is there a semaglutide shortage 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling major shift in how these Semaglutide Shortage Ends: Compounded Versions

According to FDA prescribing information, nausea affects approximately 44% of patients on Wegovy (weight management dose), while vomiting, diarrhea, constipation, and abdominal pain are also common, particularly during dose escalation

However, fruit juice or fruit packaged with added sugar will have a higher glycemic index and potentially negatively impact blood sugar levels and weight loss goals

Back Bloom, Stephen, email to Lara Marks, 17 Dec 2024

To counteract this and preserve valuable muscle mass, aim for an adequate protein intake, typically 1.01.2 grams of protein per kilogram of your ideal body weight

Holst, Wewer Albrechtsen, Gabe, Rosenkilde)

Glucagon-like peptide-1 (GLP-1) receptor agonists were investigated in 43 (72.9%) studies (Figure 4), with liraglutide being the agent used in 54.2% of all studies